252 related articles for article (PubMed ID: 17942395)
1. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.
Eckstein N; Servan K; Girard L; Cai D; von Jonquieres G; Jaehde U; Kassack MU; Gazdar AF; Minna JD; Royer HD
J Biol Chem; 2008 Jan; 283(2):739-50. PubMed ID: 17942395
[TBL] [Abstract][Full Text] [Related]
2. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
Wang X; Masri S; Phung S; Chen S
Cancer Res; 2008 Apr; 68(7):2259-65. PubMed ID: 18381432
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 induces estrogen-independence in breast cancer cells.
Roy R; Moses MA
Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
7. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
8. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
[TBL] [Abstract][Full Text] [Related]
9. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
[TBL] [Abstract][Full Text] [Related]
11. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.
Baillo A; Giroux C; Ethier SP
J Cell Physiol; 2011 Oct; 226(10):2691-701. PubMed ID: 21302279
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5.
Kato M; Inazu T; Kawai Y; Masamura K; Yoshida M; Tanaka N; Miyamoto K; Miyamori I
Biochem Biophys Res Commun; 2003 Feb; 301(4):1109-15. PubMed ID: 12589827
[TBL] [Abstract][Full Text] [Related]
13. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.
Johnson GR; Kannan B; Shoyab M; Stromberg K
J Biol Chem; 1993 Feb; 268(4):2924-31. PubMed ID: 7679104
[TBL] [Abstract][Full Text] [Related]
15. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Agelaki S; Spiliotaki M; Markomanolaki H; Kallergi G; Mavroudis D; Georgoulias V; Stournaras C
Cancer Biol Ther; 2009 Aug; 8(15):1470-7. PubMed ID: 19483462
[TBL] [Abstract][Full Text] [Related]
17. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
[TBL] [Abstract][Full Text] [Related]
18. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.
Baldys A; Göoz M; Morinelli TA; Lee MH; Raymond JR; Luttrell LM; Raymond JR
Biochemistry; 2009 Feb; 48(7):1462-73. PubMed ID: 19173594
[TBL] [Abstract][Full Text] [Related]
19. Novel role for amphiregulin in protection from liver injury.
Berasain C; García-Trevijano ER; Castillo J; Erroba E; Santamaría M; Lee DC; Prieto J; Avila MA
J Biol Chem; 2005 May; 280(19):19012-20. PubMed ID: 15753092
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
